OUD
ANANDA Scientific Announces First Patient Enrolled in the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
Ryan Allway July 26th, 2022 News, Top News GREENWOOD VILLAGE, Colo. and LOS ANGELES, July 26, 2022 /CNW/ — ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced the first patient enrolled in the clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary delivery technology as an Adjunctive Treatment for Opioid Use Disorder. (Clinical... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )